State Street Corp Ionis Pharmaceuticals Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 4,850,137 shares of IONS stock, worth $172 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,850,137

Previous 4,190,505 15.74%

Holding current value

$172 Million

Previous $200 Million 2.72%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $26.4 Million - $34.2 Million	659,632 Added 15.74%	4,850,137 $194 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $1.27 Million - $1.66 Million	34,841 Added 0.84%	4,190,505 $200 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $6.17 Million - $7.86 Million	146,867 Added 3.66%	4,155,664 $180 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $2.33 Million - $2.78 Million	53,768 Added 1.36%	4,008,797 $203 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $747,824 - $915,453	-19,424 Reduced 0.49%	3,955,029 $179 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $3.26 Million - $4.07 Million	-93,881 Reduced 2.31%	3,974,453 $163 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $5.05 Million - $6.2 Million	-150,395 Reduced 3.56%	4,068,334 $145 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $17 Million - $21.3 Million	457,774 Added 12.17%	4,218,729 $159 Million
Q3 2022 Nov 15, 2022	SELL	$36.54 - $48.66 $16.1 Million - $21.5 Million	-441,919 Reduced 10.51%	3,760,955 $166 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $5.46 Million - $7.41 Million	172,228 Added 4.27%	4,202,874 $156 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $3.71 Million - $4.6 Million	124,271 Added 3.18%	4,030,646 $149 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $9.86 Million - $13.5 Million	385,061 Added 10.94%	3,906,375 $119 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $9.74 Million - $11.8 Million	290,363 Added 8.99%	3,521,314 $118 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $6.17 Million - $8.44 Million	-178,620 Reduced 5.24%	3,230,951 $129 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $21.4 Million - $32.1 Million	-503,757 Reduced 12.87%	3,409,571 $153 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $16.2 Million - $21.6 Million	358,434 Added 10.08%	3,913,328 $221 Million
Q3 2020 Nov 10, 2020	SELL	$47.45 - $62.95 $1.69 Million - $2.24 Million	-35,529 Reduced 0.99%	3,554,894 $169 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $14.2 Million - $18.5 Million	-302,471 Reduced 7.77%	3,590,423 $212 Million
Q1 2020 May 11, 2020	BUY	$41.6 - $63.4 $162 Million - $247 Million	3,892,894 New	3,892,894 $184 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ionis Pharmaceuticals Inc Transaction History